DURECT
$1.449876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.11 (-7.14%) Today
+$0.01 (+0.70%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell DURECT and other stocks, options, ETFs, and crypto commission-free!
About DRRX
DURECT Corporation Common Stock, also called DURECT, is a biopharmaceutical company. It engages in the research, development, and manufacturing of pharmaceutical products. Read More The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Employees
90
Headquarters
Cupertino, California
Founded
1998
Market Cap
280.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.13M
High Today
$1.64
Low Today
$1.40
Open Price
$1.55
Volume
572.86K
52 Week High
$3.95
52 Week Low
$0.50
Collections
DRRX Earnings
-$0.05
-$0.03
-$0.00
$0.02
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours